In one study, Calebin-A was shown to induce G2/M cycle arrest in human colon cancer cells by lowering the levels of the proteins cdc25A, cyclin A, cyclin B, and cdc2, and raising the levels of CDKIs like P21and TP53. Here, CCNA2 is linked to malignant colon neoplasm.